The results

The highly academic development resulted in outstanding clinical performance. Through years of academic research at UCLA, the platform gradually expanded with rigorously tested functionality. In prototypic chronic diseases the platform was assessed in partnership with a US payer. It was demonstrated that both patient & provider experience and individual health outcomes while significantly lowering costs.

>
0
%
Patient Satisfaction
-
0
%
Decrease Relapse Rate
-
0
%
Decrease Physician Workload
-
0
%
Decrease Hospital Admissions

DEAR PERFORMANCE: de-escalation High Risk patients
The platform was developed at UCLA in 2011 and rigorously tested throughout the years in prototypic complex chronic diseases: Inflammatory Bowel Diseases (Crohn’s disease and Ulcerative Colitis). When looking at the Triple Aim, the experiences of patients was evaluated as very good – excellent >95%; health outcomes were significantly improved with a reduction of relapses in 46.6%; and significant cost savings were achieved including a reduction of admissions of 79,4% and reduction of ED visits of 69,4%.

Ready to implement
Implementation of our cloud-based platform requires on average 2-3 months: on the front-end, customisation to the local ecosystem is performed with provider teams. On the back-end, the platform is integrated with EMR systems. Periodically, reports are generated around Triple Aim performance: data on the user experience (patients and providers); data on disease control, quality of life and productivity; data on cost savings compared to historic costs. Demonstrating value with implementing the DEAR platform allows reimbursement opportunities with insurance companies and an ROI on the investments.

2-3 months
Implementation

Let’s optimize care for complex costly diseases together. Please contact us for additional information or request a demo.

Contact us